Cowen Aaron

CIK 00018696405 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001869640

Recent Transactions

50 trades

Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-22$12.08/sh+2,892→ 1,826,653 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-22$12.08/sh+16,650→ 9,577,475 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-19$11.48/sh+13,950→ 9,560,825 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-19$11.48/sh+2,434→ 1,823,761 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-18$11.24/sh+8,700→ 9,546,875 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-12-18$11.24/sh+1,515→ 1,821,327 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-11-07$13.50/sh+751,111→ 1,819,812 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-11-07$13.50/sh+730,370→ 9,538,175 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-31$12.63/sh+1,267→ 1,068,031 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-31$12.63/sh+9,503→ 8,802,748 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-31$13.22/sh+670→ 1,068,701 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-31$13.22/sh+5,057→ 8,807,805 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+793,800→ 8,793,245 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+106,200→ 1,066,764 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-24$11.25/sh+2,288→ 960,554 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-24$11.25/sh+17,730→ 7,999,455 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-23$10.98/sh+3,142→ 958,266 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-23$10.98/sh+24,360→ 7,981,725 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-03$9.60/sh+37,190→ 7,957,365 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-12-03$9.60/sh+4,810→ 955,124 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-11-20$10.22/sh+3,076→ 950,314 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-11-20$10.22/sh+24,360→ 7,920,175 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-11-19$9.73/sh+12,430→ 7,895,815 total
Purchase
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-11-19$9.73/sh+1,570→ 947,238 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Pre-Funded Warrants
2024-09-26−1,219,970→ 3,385,030 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Series 2 Common Warrants
2024-09-26−10,000,000→ 0 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-09-26$3.86/sh+4,605,000→ 6,663,415 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-09-26$3.86/sh+576,347→ 797,458 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common Warrants
2024-09-26−4,605,000→ 0 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Pre-Funded Warrants
2024-09-26−148,210→ 428,137 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-09-26$0.00/sh+1,219,970→ 7,883,385 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-09-26$1.93/sh+588,236→ 2,058,415 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common Warrants
2024-09-26−576,347→ 0 total
Exercise of In-Money
Benitec Biopharma Inc.$BNTC
Common stock, par value $0.0001 per share
2024-09-26$0.00/sh+148,210→ 945,668 total
Other
PROKIDNEY CORP.$PROK
Class A ordinary shares
2023-03-31+857,500→ 4,050,675 total
Other
PROKIDNEY CORP.$PROK
Class A ordinary shares
2023-03-31−3,087,000→ 3,193,175 total
Purchase
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2022-09-06$6.99/sh+7,007→ 6,280,175 total
Purchase
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2022-08-31$8.94/sh+2,100→ 6,273,168 total
Purchase
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2022-08-31$8.93/sh+1,062→ 6,271,068 total
Purchase
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2022-08-30$7.49/sh+706→ 6,270,006 total
Exercise/Conversion
Akili, Inc.
Class B ordinary shares
2022-08-19−6,220,000→ 0 total
Other
Akili, Inc.
Common Stock
2022-08-19−6,860,000→ 0 total
Exercise/Conversion
Akili, Inc.
Common Stock
2022-08-19+6,220,000→ 6,860,000 total
Exercise/Conversion
PROKIDNEY CORP.$PROK
Class A ordinary shares
2022-07-11+6,220,000→ 6,860,000 total
Other
PROKIDNEY CORP.$PROK
Class A ordinary shares
2022-07-11−6,860,000→ 0 total
Exercise/Conversion
PROKIDNEY CORP.$PROK
Class B ordinary shares
2022-07-11−6,220,000→ 0 total
Disposition to Issuer
Social Capital Suvretta Holdings Corp. II
Class B ordinary shares
2021-08-16−75,000→ 6,220,000 total
Disposition to Issuer
PROKIDNEY CORP.$PROK
Class B ordinary shares
2021-08-16−75,000→ 6,220,000 total
Disposition to Issuer
Akili, Inc.
Class B ordinary shares
2021-08-16−75,000→ 6,220,000 total
Disposition to Issuer
Social Capital Suvretta Holdings Corp. IV
Class B ordinary shares
2021-08-16−75,000→ 6,220,000 total

Companies

Recent Filings

Address

C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov